0001144204-17-033428.txt : 20170725 0001144204-17-033428.hdr.sgml : 20170725 20170621154919 ACCESSION NUMBER: 0001144204-17-033428 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20170621 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AVENUE THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001644963 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 474113275 STATE OF INCORPORATION: DE FISCAL YEAR END: 0430 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 2 GANSEVOORT STREET STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 BUSINESS PHONE: 781-652-4500 MAIL ADDRESS: STREET 1: 2 GANSEVOORT STREET STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 CORRESP 1 filename1.htm

Avenue Therapeutics, Inc.

June 21, 2017

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attn: Mr. Jeffrey Gabor

Via:	EDGAR Submission

	Re:	Avenue Therapeutics, Inc.
		Acceleration Request re. Registration Statement, as amended, on Form S-1
		(File No. 333-217552)

Ladies and Gentlemen:

Avenue Therapeutics, Inc. hereby requests that the request for acceleration of the effective date of the above-referenced Registration Statement so that it would be declared effective at 5:00 p.m., Eastern Time, on Thursday, June 15, 2017, be withdrawn.

Please contact Matthew W. Mamak of Alston & Bird LLP with any questions or comments at 212-210-1256.

	AVENUE THERAPEUTICS, INC.

	By:	/s/ Lucy Lu
		Lucy Lu
		Chief Executive Officer

cc:	Matthew W. Mamak, Esq.